CD274 and melanoma: Moreover, the study found that GLO1 KO condition reduced PDL1 expression, both at the mRNA and protein levels (GLO1 WT versus GLO1 KO [B40 and C2]), a noteworthy finding given the significance of PD-L1 as a key target for clinically relevant melanoma immunotherapeutic intervention [128].